Objectives: (1) To characterize and calibrate an electrodermal screening device, Prognos. (2) To replicate a previous test-retest reliability study of this device with measurements of electrical skin resistance (ESR) at 24 Jing-well acupuncture points (APs). (3) To determine measurement precision in three successively more exacting trial protocols on the same set of subjects.
INTRODUCTION E
lectrodermal screening at acupuncture points (APs) is utilized by clinicians worldwide (Tiller, 1989; Tsuei et al., 1995) despite the relatively few studies that have evaluated instrument and/or measuring technique reliability (Jessel-Kenyon et al., 1995; Lam et al., 1988; Treugut et al., 1998) . This practice is based on an underlying assumption that the electrical resistance/conductivity at APs, although less easily defined than the electrical fields detected with electroencephalograms, electrocardiograms, and electromyograms, is nevertheless measurable and indicative of pathophysiologic changes in related organs.
Electrodermal testing of APs developed as a consequence of 1950s research in France, Japan, and Germany (Nakatani, 1953 (Nakatani, , 1972 Niboyet, 1951 Niboyet, , 1957 Voll, 1975) . These three independent investigators found that skin surface sites corresponding to APs have lower electrical resistance/impedance (and consequent higher conductance) than surrounding sites, and that "abnormal" values at APs were indicators of dysfunction in the related meridians and organs. These epidermal bioelectric properties at APs have been observed by numerous subsequent researchers (reviewed in Tiller, 1989; Zhu, 1981; Zhang 2002) . Of particular interest are a range of clinical trials in animals and humans that have demonstrated correlations between alterations in electrodermal measurements at specific APs and disease states (Falk et al., 2000; Kawakita et al., 1991; Lam and Tsuei, 1983; Matsumoto and Hayes, 1973; Oleson et al., 1980; Saku et al, 1993; Sullivan et al., 1985; Tsuei et al., 1984 Tsuei et al., , 1989 Zhu et al., 2001) .
A cautionary outcome of research in this field is the general agreement that electrical skin resistance (ESR) measurements are vulnerable to three frequently encountered sources of imprecision: (1) instrument error resulting from the size, pressure, and duration of probe application; (2) local skin conditions such as variable thickness, hydration, and intactness of the stratum corneum; and (3) the physiologic and pathologic functional state of the organism. Several researchers even argue that because of the high potential for measurement artifact, a meaningful decrease in resistance at APs has not been adequately proved (Martinsen et al., 2001; McCarroll and Rowley, 1979; Noodergraf and Silage, 1973) .
During a search for a means to assess ESR levels at APs as a potential biomarker for clinical trials of acupuncture, we became aware of Prognos, an electrodermal device developed in the USSR's space program as a health maintenance system for their cosmonauts (www.germanmedtec. com/Download/Prognos-dl1/Info.html).
The existence of promising test-retest reliability findings for Prognos also weighed in its favor (Treugut et al., 1998) . Our objectives for the present study were to characterize and calibrate a Prognos device in regard to the manufacturer's specifications, to replicate the prior test-retest reliability investigation, and to perform further reliability testing under sequentially more precise experimental conditions. A preliminary report of our findings has been presented (Colbert et al., 2003) .
MATERIALS AND METHODS

Instruments
The Prognos device was reputedly designed specifically to overcome three instrument-related artifacts: probe size and pressure and duration of probe application, by utilizing a small (4.57-mm diameter) flexible, spring-loaded probe tip and by calculating an average ESR value from 400 measurements taken in approximately 200 ms (www.germanmedtec.com/Download/Prognos-dl2/Manual.html).
Prior to use in the clinical test-retest reliability studies our test instrument, a single Prognos device (version 3; software version 2.4), rented from a practitioner in southern Washington State, was characterized and calibrated by a team of research engineers led by one of the authors (J.M.) at the Biomedical Signal Processing Laboratory of Portland State University. The device is essentially an ohmmeter (MedPrevent, Waldershof, Germany) consisting of a power source connected by a cable to the measuring probe and a reference electrode (6 ϫ 3.5 cm) that is attached with a Velcro strap to the volar surface of the forearm. Impedance measurements recorded as direct current (DC) analogue values are taken while holding the probe at a 90°angle to the AP (Fig. 1) . The analogue values are fed into an amplifier in the Prognos and transformed into a digital value by an A/D converter. A digital screen on the device displays the measured resistance values in kilo-ohms (k⍀). The data are then imported to a laptop compuuter via a serial cable.
The probe tip, which has a maximum excursion of 6.91 mm is connected to a linear spring and lies flush in a plastic insulation at the end of a plastic cylinder (Fig. 1) a photodetector. The spring loaded probe disrupts the light beam and triggers a reading at an average tip deflection of 2.90 mm with an average force of 2.68 Ϯ 0.05 N (n ϭ 6). When triggered, the Prognos applies 1.1 A current from the forearm strap to the probe tip for an average of 223 Ϯ 3 ms (n ϭ 7). Device calibration focused mainly on the accuracy and repeatability of measurements over a broad range of known resistors. The resistance reported by Prognos was compared with that measured by a standard Fluke 87 multimeter over 50 different resistors ranging from 150 k⍀ to 14 M⍀. The repeatability of measurements was also assessed by measuring the same resistance four separate times for n ϭ 25 different resistances. The single Prognos device tested in this study measured resistance accurately over the range 150 k⍀ to 14.3 M⍀, although it appears to have a slightly positive bias for large impedances (Fig. 2) .
Participants for clinical reliability testing
The research protocol was approved by the Institutional Review Board of the Oregon College of Oriental Medicine (OCOM) and by the Data Safety Monitoring Board of the Oregon Center for Complementary and Alternative Medicine, Kaiser Permanente Center for Health Research. Participants were recruited from the student body and faculty of OCOM. Potential participants were assured that their decision to participate or not would have no influence on their relationship with the college. Written informed consent was obtained from all participants. Inclusion criteria were: 18 years of age or older, good general health, and the ability to rest calmly during measurements. Exclusion criteria were: any chronic or acute health problem, or visually observable skin irregularities such as cracking, lacerations, bruises, dermatologic conditions, or excessive dryness at or near the finger or toe nailbeds. Thirty-three (33) individuals met the entry criteria, 31 of whom completed the study protocol; 2 did not come on the scheduled day of testing. Participants were instructed not to eat for 2 hours prior to scheduled testing.
Procedures
All measurements took place at OCOM on February 8, 9, and 10, 2003 between 9 AM and 7 PM. Testing was not limited to certain times of the day because reliability of ESR measurements rather than absolute values was the focus of the study. Ambient temperature during testing ranged from 61°F to 72°F.
The experimenter (A.P.C.) who took all measurements, was trained in the use of the Prognos over a 2-day observation and practice session with a clinician who had been using the device for 1 year. The computer screen on which data was recorded was positioned out of the line of sight of the experimenter. A research assistant, not involved in data analysis, monitored the data input. The Prognos device was connected to a PC (Dell Inspiron 3800 laptop, Dell Inc., Round Rock, TX; Windows 98 Operating System) through a serial port; data was acquired using Medprevent's Prognos software (version 2.4). The data were saved in a softwarespecific format and then manually entered into Microsoft Excel for subsequent analysis. (At the time of the study the software necessary for transferring data electronically from Prognos to Microsoft Excel was not available to us.)
Participants were asked to lie quietly on an examining table for 10 minutes prior to testing. They were told that the research involved reliability testing of a device only, that measurements were not being taken for diagnostic or therapeutic purposes and that they would not be informed of their individual results. Skin preparation included cleansing the skin at the nailbeds corresponding to all Jing-well APs with a 70% ethyl alcohol swab. The 24 Jing-well acupuncture points (also called Ting points), located at the corners of the nailbeds on the fingers and toes, are important in acupuncture practice because they represent either the beginning or end of each of the 12 paired meridians and are used clinically to treat a variety of acute conditions. The reference electrode was secured with a Velcro strap to the right forearm 3 inches above the wrist. All measurements were taken with the participant supine on the examining tables, positioned such that they were unable to observe the recordings being made. Electrical skin resistance at all 24 Jingwell APs was recorded during three trial protocols performed consecutively on each subject. The three test protocols described below were intended to reflect: standard clinical practice (trial 1); clinical practice with the advantage of consistency of probe placement by ink-marking the APs (trial 2); and increased measuring precision with 4 rapid repeat recordings (trial 3). recordings at each of 24 APs per trial), took between 15-20 minutes per subject.
Trial 1. The Prognos probe tip was applied sequentially to each Jing-well AP, proceeding from right hand to right foot to left foot to left hand. No conductive lubricant was used. The APs on each side were measured in the order LU 11, LI 1, MH 9, TH 1, HT 9, SI 1, SP 1, LR 1, ST 45, GB 44, KD 1, BL 67. Acupuncture point KD 1 was recorded at the medial corner of the nailbed of the small toe.
Trial 2. At the conclusion of Trial 1 on each subject, the 24 APs were marked by the experimenter with nontoxic, washable ink. The ink was allowed to dry for 1 minute and measurements were taken in the same fashion as described in Trial 1 at the marked APs.
Trial 3. At the conclusion of Trial 2, a third set of measurements was taken by recording four ESR readings in rapid succession at each Jing-well AP before moving on to the next point. The order of points being measured was the same as in the first and second trials.
Statistical methods
Two hundred and eighty-eight (288) measurements from each of the 31 subjects were subjected to statistical analysis. The between-and within-components of variance were computed across participants at each point separately, using a standard method (Winer, 1962) . The reliability of a single measurement was estimated as the ratio of the between person variance to the total variance. To assess whether there were systematic differences in the level of measurements between the three different trial protocols, paired t tests were applied to the individual mean resistances, separately at each point. 
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RESULTS
Clinical test-retest measurements of twenty-four Jing-well APs
The 31 healthy participants on whom ESR was measured at the 24 Jing-well points were 17 females and 14 males, 24 to 63 years of age (mean, 32.7 years). All completed the three trials. Mean values of ESR (in k⍀) and reliability for individual APs from all three trials are presented in Table 1 .
The mean reliability for Trial 1 (standard clinical protocol) was 0.758, with a range of 0.538 (right HT 9) to 0.882 (left GB 44). When the APs were marked with nontoxic washable ink and remeasured in Trial 2, the mean reliability of a single measurement increased to 0.850; range, 0.690 (right HT 9) to 0.963 (right BL 67). The highest mean reliability of 0.959; range, 0.891 (right HT 9) to 0.987 (left LI 1) was obtained in Trial 3, when four measurements at each marked point were made in rapid succession.
In general, higher reliability correlated with lower mean ESR. This trend is exemplified in Trial 1 by Jing-well acupuncture point left GB 44, which had the highest mean reliability and lowest ESR readings (Fig. 3) and Jing-well point right HT 9, which had the lowest mean reliability and highest ESR recordings (Fig. 4) . In both cases, the inverse relation of ESR value and reliability was seen across subjects.
Mean ESR measurements in Trial 2, where the APs were marked for consistency of probe placement on repeat measurements, were significantly lower than in Trial 1 (unmarked points) at all but 2 APs. Means in Trial 2 were approximately 1 (within-person) standard deviation lower than in Trial 1. No further significant decrease in mean ESR was observed between Trials 2 and 3.
Among right-side measurements, there were significant differences in reliability between the yang and yin organs in both Trials 1 and 2. In both cases, the yang organ measurements were more reliable than the yin organ measurements (trial 1, p ϭ 0.0014; trial 2, p ϭ 0.0389). A comparison of the reliabilities of overall mean left side versus right side measurements showed greater reliability at four of the left side points: LI, ST, HT and SI.
DISCUSSION
Characterization and calibration of a commercially available Prognos by a team of research engineers demonstrated that the device performs accurately and records repeatable measurements of known resistances. The linear spring design feature of the device improves measurement reproducibility by minimizing fluctuations in the probe's contact surface area and diminishing pressure artifacts that often confound ESR studies.
Our Trial 1 test-retest protocol, a simulation of standard clinical measuring procedure, produced comparable reliability results (0.758 versus 0.721) to those reported by Treugut et al. (1998) . Marking the APs with ink for consistency of probe placement was found to give greater precision (r ϭ 0.850 in Trial 2) than when applying the probe tip to unmarked APs (Trial 1). Furthermore, when the measurement technique was made even more precise, by performing four measurements at each marked Jing-well AP in rapid succession, the reliability of Prognos measurements again increased (0.959 in Trial 3). Within each test protocol, there was variation in both the means and the withinperson standard deviations of the ESR measurements, indicating the possibility of important variations between the different APs. Interest in the present study, however, centered on systematic differences in overall means between the three trial protocols.
The improved reliability in Trials 2 and 3 coincided with lower absolute values of mean resistance than were recorded in Trial 1. Measurements in these two trials were made on inked APs. It is possible that the markedly lower resistance measured under the Trial 2 protocol compared to Trial 1 might be related to the ink used for marking the points, despite the fact that the ink was allowed to dry prior to taking
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Multiple ESR Recordings for Individual Subjects in Trial 1 Electrical Skin Resistance (k9) measurements. Previous researchers found no apparent influence on subsequent ESR measurements after inking APs (Falk et al., 2000; Margolin et al., 1996) . The lower ESR values that might have resulted from inking have no implications for reliability studies in which the marked AP protocol is used for all measurements, if comparisons are always made on the basis of recordings taken under the same conditions. A calibration issue, however, would arise if attempts were made to compare the absolute values of mean ESR in an unmarked protocol to the same values obtained in a marked protocol. It is worth pointing out that even Trial 1 measurements in which the APs were not inked are, by the general standard in medicine, very reliable. For example, a reliability of 0.75 exceeds the reliability of a research level repeat blood pressure measurement (average of two readings using a random zero sphygmomanometer), which lies in the 0.60-0.70 range (where within-person variability is over days in the same week based on data from the DASH study (Appel et al., 1997) Our subanalyses differ somewhat from those of Treugut et al. (1998) who found measurements in the yin organs to be significantly more reliable than those in the yang organs and no difference between right and left sided recordings. In the present study, the yang organ measurements in Trials 1 and 2 were more reliable than the yin organ measurements. Also, greater reliability was observed for Prognos readings of the left LI, ST, SI, and HT than corresponding APs on the right. These differences between the two studies with similarly low sample sizes should be considered inconclusive and need to be further explored with substantially larger samples. Dissimilarities between left/right, upper body/lower body, and yin/yang meridians are described as having considerable diagnostic relevance (Medprevent Instruction Manual, 2000; Tsuei, 1996; Motoyama, 1997) and will be investigated in future trials.
Four major electrodermal screening procedures and instruments are in common clinical use: the Neurometer or Electro Meridian Imaging utilizing the Ryodoraku method (Amaro, 2002) , the Apparatus for measuring the condition of the Meridians and their corresponding Internal organs (AMI; Motoyama, 1997) , electroacupuncture according to Voll (EAV) devices using Voll's techniques (Lam, 1998) and Prognos (Treugut et al., 1998) . The Ryodoraku method and Motoyama's AMI device test 28 Jing-well APs, including measurements on the lateral corner of the middle fingers and the medial corners of the middle toes not assessed with the Prognos protocol. The EAV system on the other hand utilizes a completely different set of points representing none of the classical APs (Voll, 1978) . We chose to evaluate the Prognos device and system of measurement because it was the system on which at least one rigorous test-retest reliability experiment had already been performed (Treugut et al., 1998) . In addition, Prognos appeared to be the most user-friendly commercially available device. Other electrodermal systems in current usage engage complex measuring techniques, requiring extensive training and skilled interpretation of the results, and are considered to have relatively poor inter-rater reliability (Tsuei et al., 1988) .
If ESR readings at APs are to be established as standard medical biomarkers, a fundamental research question to be answered is whether the instrument is accurate and reliable. The Prognos device has passed this first test. The next phase of our research will investigate physiological variability of ESR measurements at APs over time. In the present study, we sought to minimize this variability as much as possible by limiting our exploration to the three trial protocols over a 15-20 minute period in each individual.
Other larger questions to be answered are: What underlying physiologic phenomena do ESR measurements at APs actually delineate? Do they parallel galvanic skin response recordings? Are they correlates of heart rate variability measurements reflecting the state of the autonomic nervous system? Do ESR measurements at APs consistently represent pathophysiologic changes in related internal organs as demonstrated by several researchers (Bergsmann and Wooley-Hart, 1973; Matsumoto and Hayes, 1973; Motoyama, 1997 Motoyama, , 1999 Oleson 1980; Rosenblatt, 1982; Saku, 1993; Tsuei et al., 1996; Zhu et al., 2001) ? Clearly, the goal of establishing sensitivity and specificity of ESR testing at APs will be a substantial undertaking. Acknowledging the challenge, we nonetheless agree with Tiller (1989) who proposed that electrodermal diagnosis holds promise as a rapid, inexpensive, and potentially accurate diagnostic method for detecting incipient illness. The present replication of the test-retest reliability of Prognos (Treugut et al., 1998 ) is a first step in standardizing the research methodology needed to evaluate whether electrical measurements at acupuncture points can be developed into reliable biomarkers for early detection of disease.
CONCLUSION
A Prognos resistance detector was characterized and calibrated for accuracy and reliability. It was shown to perform in accordance with the manufacturer's specifications and when tested on 31 individuals over a 15-20 minute time span, was found to reliably measure ESR at Jing-well APs. We conclude that electrical resistance measurements at the 24 Jing-well APs, when measured with the Prognos, can be regarded as sufficiently reliable in a biomedical research setting. The Prognos appears to be the only electrodermal device for measuring acupuncture points that has been tested for reproducibility by two separate teams of researchers and proven to be reliable in both settings. This study has established the necessary foundation on which further investigations of ESR at APs can be built.
Health (AT00076) through the Oregon Center for Complementary and Alternative Medicine. We would like to thank Tom Narvaez for his valuable instruction on the use of Prognos and Alesha Estes for her contributions as software programmer and research assistant.
